Literature DB >> 3742881

Platelet-derived factors enhance pemphigus acantholysis in skin organ cultures.

T Hunziker, U E Nydegger, P G Lerch, J D Vassalli.   

Abstract

Supernatant fluids were prepared from human platelets (2-2.5 X 10(10)/ml) after sonication of stimulation with cross-linked IgG; together with plasma samples from two patients with different types of pemphigus, they enhanced acantholysis in cultured punch biopsy specimens of human skin. In the absence of pemphigus plasma the platelet-derived materials did not induce acantholysis. The acantholysis-enhancing effect persisted after exhaustive dialysis or heating (56 degrees C, 30 min). The platelet-derived materials did not contain plasminogen activator; plasminogen itself was detectable by zymographic analysis, although in quantities too low (0.2-0.5 micrograms/ml) to account for the acantholysis-enhancing activity. We conclude that the platelet could contribute to the pathogenesis of pemphigus. The nature of the platelet-derived acantholysis-enhancing factors is presently unknown.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3742881      PMCID: PMC1542357     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  33 in total

1.  Identification of the platelet activating activity in rheumatoid synovial fluid as an intermediate molecular weight complex of IgG.

Authors:  F H Valone; K F Austen; E J Goetzl
Journal:  J Immunol       Date:  1979-02       Impact factor: 5.422

2.  Studies on the metabolism of human blood platelets in relation to clot retraction.

Authors:  M BETTEX-GALLAND; E F LUSCHER
Journal:  Thromb Diath Haemorrh       Date:  1960-03-01

3.  Characterization of cryoprecipitates in pemphigus: demonstration of pemphigus antibody activity in cryoprecipitates using the immunofluorescent technique.

Authors:  S Miyagawa; K Sakamoto
Journal:  J Invest Dermatol       Date:  1977-10       Impact factor: 8.551

4.  Corticosteroids, aurothioglucose and soybean trypsin inhibitor do not prevent pemphigus antibody-induced acantholysis in vitro.

Authors:  J R Schiltz; C H Hu; B Michel
Journal:  Br J Dermatol       Date:  1979-09       Impact factor: 9.302

5.  C1q binding substances in pemphigus and bullous pemphigoid. Detection with a [131I] C1q binding assay.

Authors:  G Tappeiner; K G Heine; J C Kahl; R E Jordon
Journal:  Clin Exp Immunol       Date:  1977-04       Impact factor: 4.330

6.  Isolation of plasmin-free human plasminogen with N-terminal glutamic acid.

Authors:  E E Rickli; P A Cuendet
Journal:  Biochim Biophys Acta       Date:  1971-11-13

7.  Bactericidal activity and chemotaxis in pemphigus vulgaris and bullous pemphigoid.

Authors:  A R Ahmed; B J Ank; S E Gard; E R Stiehm
Journal:  J Am Acad Dermatol       Date:  1982-06       Impact factor: 11.527

8.  Detection of class-specific antibodies of pemphigus vulgaris using a solid phase radioimmunoassay.

Authors:  R I Murahata; A R Ahmed
Journal:  J Invest Dermatol       Date:  1982-08       Impact factor: 8.551

9.  Pemphigus provoked by D(-)penicillamine. An experimental approach using in vitro tissue cultures.

Authors:  V Ruocco; M de Luca; M Pisani; E de Angelis; O Vitale; C Astarita
Journal:  Dermatologica       Date:  1982-04

10.  A study of proteases and protease-inhibitor complexes in biological fluids.

Authors:  A Granelli-Piperno; E Reich
Journal:  J Exp Med       Date:  1978-07-01       Impact factor: 14.307

View more
  3 in total

1.  Experimental human cell and tissue models of pemphigus.

Authors:  Gerda van der Wier; Hendri H Pas; Marcel F Jonkman
Journal:  Dermatol Res Pract       Date:  2010-05-26

2.  Plasmin induces acantholysis in skin organ cultures.

Authors:  T Hunziker; J D Vassalli
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

3.  Gene Expression Analysis Reveals Novel Shared Gene Signatures and Candidate Molecular Mechanisms between Pemphigus and Systemic Lupus Erythematosus in CD4+ T Cells.

Authors:  Tanya Sezin; Artem Vorobyev; Christian D Sadik; Detlef Zillikens; Yask Gupta; Ralf J Ludwig
Journal:  Front Immunol       Date:  2018-01-17       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.